Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cumberland Pharmaceu (CPIX)

Cumberland Pharmaceu (CPIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 48,355
  • Shares Outstanding, K 15,017
  • Annual Sales, $ 47,530 K
  • Annual Income, $ -3,540 K
  • 60-Month Beta 0.32
  • Price/Sales 0.99
  • Price/Cash Flow 6.14
  • Price/Book 1.01
Trade CPIX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.03
  • Number of Estimates 1
  • High Estimate -0.03
  • Low Estimate -0.03
  • Prior Year 0.07
  • Growth Rate Est. (year over year) -142.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.90 +13.79%
on 12/29/20
3.58 -7.82%
on 01/22/21
+0.22 (+7.14%)
since 12/22/20
3-Month
2.77 +19.13%
on 11/02/20
3.58 -7.82%
on 01/22/21
+0.30 (+10.00%)
since 10/22/20
52-Week
2.77 +19.13%
on 11/02/20
5.08 -35.04%
on 01/24/20
-1.74 (-34.52%)
since 01/22/20

Most Recent Stories

More News
Introducing RediTrex®, A New Methotrexate Delivery System

, /PRNewswire/ -- , a U.S. specialty pharmaceutical company, announced today the launch of RediTrex (methotrexate) injection. RediTrex is a new line of pre-filled syringes specifically designed for ease...

CPIX : 3.30 (+2.48%)
Cumberland Pharmaceuticals (CPIX) Q3 Earnings and Revenues Surpass Estimates

Cumberland (CPIX) delivered earnings and revenue surprises of 128.57% and 7.45%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

CPIX : 3.30 (+2.48%)
Cumberland: 3Q Earnings Snapshot

NASHVILLE, Tenn. (AP) _ Cumberland Pharmaceuticals Inc. (CPIX) on Tuesday reported a loss of $482,000 in its third quarter.

CPIX : 3.30 (+2.48%)
Cumberland Pharmaceuticals Reports Third Quarter 2020 Financial Results & Company Update

, /PRNewswire/ -- (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and third quarter 2020 financial results. Net revenues from continuing operations during the...

CPIX : 3.30 (+2.48%)
Cumberland Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 10, 2020 / Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on November...

CPIX : 3.30 (+2.48%)
Cumberland Pharmaceuticals To Announce Third Quarter 2020 Financial Results

, /PRNewswire/ -- (NASDAQ: CPIX) announced today that it will release third quarter 2020 financial results and Company update after the market closes on . A conference call and live internet webcast...

CPIX : 3.30 (+2.48%)
Earnings Preview: Cumberland Pharmaceuticals (CPIX) Q3 Earnings Expected to Decline

Cumberland (CPIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CPIX : 3.30 (+2.48%)
Newly Published Literature Supports Use Of Caldolor® For Postoperative Pain And Reduction Of Opioid Use

, Aug. 18, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced the results of a new review of clinical studies evaluating Caldolor...

CPIX : 3.30 (+2.48%)
Cumberland Pharmaceuticals (CPIX) Q2 Earnings and Revenues Beat Estimates

Cumberland (CPIX) delivered earnings and revenue surprises of 166.67% and 3.54%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

CPIX : 3.30 (+2.48%)
Cumberland: 2Q Earnings Snapshot

NASHVILLE, Tenn. (AP) _ Cumberland Pharmaceuticals Inc. (CPIX) on Tuesday reported a loss of $918,000 in its second quarter.

CPIX : 3.30 (+2.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in...

See More

Key Turning Points

3rd Resistance Point 4.01
2nd Resistance Point 3.79
1st Resistance Point 3.55
Last Price 3.30
1st Support Level 3.09
2nd Support Level 2.87
3rd Support Level 2.63

See More

52-Week High 5.08
Fibonacci 61.8% 4.20
Fibonacci 50% 3.92
Fibonacci 38.2% 3.65
Last Price 3.30
52-Week Low 2.77

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar